Cow’s milk allergy as a cause of anaphylaxis to systemic corticosteroids

Savvatianos, Savvas; Giavi, Stavroula; Stefanaki, E.; Siragakis, George; Manousakis, Emmanouil; Papadopoulos, Nikolaos G.

doi:10.1111/j.1398-9995.2011.02566.x

Cited by 24 publications

(11 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Allergic reactions are consequently highly unlikely in most allergic individuals. Clearly, where they do occur, lactose‐free alternatives are recommended .…”

Section: Pharmaceutical Agents Containing Milkmentioning

confidence: 99%

BSACI guideline for the diagnosis and management of cow's milk allergy

Luyt

Ball

Makwana

et al. 2014

Clin Experimental Allergy

323

359

View full text Add to dashboard Cite

SummaryThis guideline advises on the management of patients with cow's milk allergy. Cow's milk allergy presents in the first year of life with estimated population prevalence between 2% and 3%. The clinical manifestations of cow's milk allergy are very variable in type and severity making it the most difficult food allergy to diagnose. A careful age-and diseasespecific history with relevant allergy tests including detection of milk-specific IgE (by skin prick test or serum assay), diagnostic elimination diet, and oral challenge will aid in diagnosis in most cases. Treatment is advice on cow's milk avoidance and suitable substitute milks. Cow's milk allergy often resolves. Reintroduction can be achieved by the graded exposure, either at home or supervised in hospital depending on severity, using a milk ladder. Where cow's milk allergy persists, novel treatment options may include oral tolerance induction, although most authors do not currently recommend it for routine clinical practice. Cow's milk allergy must be distinguished from primary lactose intolerance.

show abstract

“…Allergic reactions are consequently highly unlikely in most allergic individuals. Clearly, where they do occur, lactose‐free alternatives are recommended .…”

Section: Pharmaceutical Agents Containing Milkmentioning

confidence: 99%

BSACI guideline for the diagnosis and management of cow's milk allergy

Luyt

Ball

Makwana

et al. 2014

Clin Experimental Allergy

323

359

View full text Add to dashboard Cite

show abstract

“…Consequently, an intravenous methylprednisolone sodium succinate 40 mg injection provoked anaphylactic reactions or urticaria in children with severe CMA [56,57,58,59]. Noteworthy, skin tests were positive to methylprednisolone sodium succinate 40 mg injection and negative to lactose-free methylprednisolone formulation [56,57,58,59]. The European Medical Agency has contraindicated intravenous methylprednisolone sodium succinate 40 mg in children with CMA or suspected CMA [60].…”

Section: Cow’s Milkmentioning

confidence: 99%

Hazardous Medications in Children with Egg, Red Meat, Gelatin, Fish, and Cow’s Milk Allergy

et al. 2019

View full text Add to dashboard Cite

Childhood food allergies are a growing public health problem. Once the offending food allergens have been identified, a strict elimination diet is necessary in treatment or prevention of most of the allergic reactions. Accidental food ingestion can lead to severe anaphylaxis. Food- derived substances can be used in medications at various stages of the manufacturing process. In this review, the possible roles of medications which may contain egg, red meat, gelatin, and fish allergens on allergic reactions in children with food allergy were evaluated.

show abstract

“…Few cases have been reported with possible hypersensitivity reactions in children with asthma and cow’s milk allergy due to milk protein traces in inhaled corticosteroids [ 203 – 205 ].…”

Section: Adverse Effects Of Icsmentioning

confidence: 99%

The use of inhaled corticosteroids in pediatric asthma: update

Hossny

Rosário

Lee

et al. 2016

World Allergy Organization Journal

View full text Add to dashboard Cite

Despite the availability of several formulations of inhaled corticosteroids (ICS) and delivery devices for treatment of childhood asthma and despite the development of evidence-based guidelines, childhood asthma control remains suboptimal. Improving uptake of asthma management plans, both by families and practitioners, is needed. Adherence to daily ICS therapy is a key determinant of asthma control and this mandates that asthma education follow a repetitive pattern and involve literal explanation and physical demonstration of the optimal use of inhaler devices. The potential adverse effects of ICS need to be weighed against the benefit of these drugs to control persistent asthma especially that its safety profile is markedly better than oral glucocorticoids. This article reviews the key mechanisms of inhaled corticosteroid action; recommendations on dosage and therapeutic regimens; potential optimization of effectiveness by addressing inhaler technique and adherence to therapy; and updated knowledge on the real magnitude of adverse events.

show abstract

Cow’s milk allergy as a cause of anaphylaxis to systemic corticosteroids

Cited by 24 publications

References 6 publications

BSACI guideline for the diagnosis and management of cow's milk allergy

BSACI guideline for the diagnosis and management of cow's milk allergy

Hazardous Medications in Children with Egg, Red Meat, Gelatin, Fish, and Cow’s Milk Allergy

The use of inhaled corticosteroids in pediatric asthma: update

Contact Info

Product

Resources

About